Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Double-Blind, Placebo- and Active-Controlled, Dose-Ranging Study to Evaluate the Analgesic, Efficacy, Safety and Tolerability of Intravenous N1539 in Subjects After Open Abdominal Hysterectomy

NCT01084161 is registered in ClinicalTrials.gov with Alkermes, Inc. as lead sponsor.

NCT NCT01084161
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01084161 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Double-Blind, Placebo- and Active-Controlled, Dose-Ranging Study to Evaluate the Analgesic, Efficacy, Safety and Tolerability of Intravenous N1539 in Subjects After Open Abdominal Hysterectomy
Lead sponsor
Alkermes, Inc.
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2010
Completion date
January 31, 2011
Enrollment
486 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

hysterectomy